Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

1. OS0849

   Isavuconazole IV to oral step-down therapy versus caspofungin followed by voriconazole oral step-down therapy in the treatment of candidaemia and invasive candidiasis (IC): the ACTIVE trial

   Barrie Anthony, Horsham, United Kingdom

   George Thompson, George Alangaden, Rodrigo Santos, Claudio Viscoli, Laura Kovanda, Christopher Lademacher, Rodney Croos-Dabrera, Marc Engelhardt, Cesar Escrig, Bart Jan Kullberg

   25 April 2017

   Session: Challenges in antifungal treatment

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Fungal Infection & Disease

2. OS0850

   A new in vitro  endpoint of anidulafungin activity against Aspergillus fumigatus correlates with in vivo outcome

   Maria Siopi, Athens, Greece

   Maria Siopi, Johan Mouton, Spyros Pournaras, Joseph Meletiadis

   25 April 2017

   Session: Challenges in antifungal treatment

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Fungal Infection & Disease

3. OS0854

   Isavuconazole prophylaxis among solid organ transplant recipients: effectiveness and drug interaction with tacrolimus

   Cornelius Clancy, Pittsburgh, PA, United States

   Ryan Rivosecchi, Cornelius Clancy, Ryan Shields, Bonnie Falcione, Abhi Humar, Minh-Hong Nguyen

   25 April 2017

   Session: Challenges in antifungal treatment

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Fungal Infection & Disease

4. OS0851

   Comparison of treatment appropriateness defined by previous, current CLSI and EUCAST breakpoints and their association with mortality in candidaemia

   Nesrin Ghanem-Zoubi, Haifa, Israel

   Nesrin Ghanem-Zoubi, Danny Zorbavel, Johad Khoury, Yuval Geffen, Roni Bitterman, Mical Paul

   25 April 2017

   Session: Challenges in antifungal treatment

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Fungal Infection & Disease

5. OS0848

   Pharmacodynamics of F901318 against Aspergillus fumigatus in a rabbit model of invasive pulmonary aspergillosis (IPA)

   William Hope, Liverpool, United Kingdom

   William Hope, Laura McEntee, Adam Johnson, Nikki Farrington, Sarah Whalley, Anahi Santoyo-Castelazo, Mike Birch, Derek Law, Tony Kennedy, Markus Heep, John Rex

   25 April 2017

   Session: Challenges in antifungal treatment

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Fungal Infection & Disease

6. OS0847

   In-vitro activity of F901318 and comparators against clinical isolates of cryptic species of Aspergillus

   Ana Alastruey-Izquierdo, Majadahonda, Madrid, Spain

   Olga Rivero-Menéndez, Laura Beltrán-Sangüesa, Ana Alastruey-Izquierdo

   25 April 2017

   Session: Challenges in antifungal treatment

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Fungal Infection & Disease

7. OS0846

   A prospective, phase 2, multicentre, open-label, randomized, comparative study to estimate the safety, tolerability, pharmacokinetics, and efficacy of oral SCY-078 vs standard-of-care following initial intravenous echinocandin therapy in the treatment of

   Thomas Chen, Sudbury, MA, United States

   Peter G. Pappas, John Pullman, George Thompson, Andrej Spec, Ellis Tobin, Jose Vazquez, David Angulo Gonzalez, Silvia Helou

   25 April 2017

   Session: Challenges in antifungal treatment

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Fungal Infection & Disease

8. OS0855

   Antifungal prophylaxis in AML patients receiving intensive induction chemotherapy. A prospective observational study from the Acute Leukemia French Association (ALFA) group

   Mauricette Michallet, Pierre Benite, France

   Mauricette Michallet, Mohamad Sobh, Alexandre Deloire, Emmanuel Raffoux, Stephane Debotton, Denis Caillot, Oumedali Reman, Stephane Girault, Celine Berthon, Francoise Huguet, Stephane Lepretre, Thibaut Leguay, Sylvie Castaigne, Bruno Royer, Cecile Pautas, Jean-Valere Malfuson, Jose Fernandes, Herve Dombret, Xavier Thomas, Anne Bergeron

   25 April 2017

   Session: Challenges in antifungal treatment

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Fungal Infection & Disease

9. OS0852

   Management and outcome of culture-positive invasive aspergillosis in an area with high prevalence of voriconazole resistance

   Robbert Bentvelsen, Leiden, The Netherlands

   Robbert Bentvelsen, P.p.a. Lestrade, Judith Van Paassen, Daphne W.L. Scoop, Peter Von dem Borne, Willem Melchers, Paul Eduard Verweij, Martha Van der Beek, Ed J. Kuijper

   25 April 2017

   Session: Challenges in antifungal treatment

   Relevance:

    

   100%

    

   

   Event: ECCMID 2017
   Vienna, Austria
   Oral presentation

   Fungal Infection & Disease

10. OS0853

    Audit of voriconazole therapeutic drug monitoring in an English hospital after the implementation of electronic prescribing (EPIC)

    David Enoch, Cambridge, United Kingdom

    Sarah Trimble, Christianne Micallef, Reem Santos, Mark Leamon, David Enoch

    25 April 2017

    Session: Challenges in antifungal treatment

    Relevance:

     

    100%

     

    

    Event: ECCMID 2017
    Vienna, Austria
    Oral presentation

    Fungal Infection & Disease